4don MSN
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...
Dr. Steven Henikoff, a molecular biologist at Fred Hutch Cancer Center, has won the prestigious Rosenstiel Award for ...
Communication between epithelial and mesenchymal cells in pancreatic cancer leads to a poor prognosis. The molecular basis ...
News-Medical.Net on MSN
TROP2 identified as a promising therapeutic target for renal medullary carcinoma
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...
News-Medical.Net on MSN
Researchers identify new molecular switch involved in programmed cell death
In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It ...
Cancer thrives by hijacking the body's own basic survival systems, making it hard to attack tumors without collateral damage and side effects. Now, researchers at Cornell's Weill Institute for Cell ...
GAINESVILLE, Fla. (WCJB) - In this week’s Tech Tuesday, our partners at UF Innovate and SCAD Media highlight Myosin ...
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 The question of whether to change tumor naming is a very ...
Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...
Mythreye Karthikeyan, Ph.D., an associate professor in the Division of Molecular and Cellular Pathology, has been appointed Co-Leader of the UAB O'Neal Comprehensive Cancer Center's Cancer Biology and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback